Gigacloud Technology Inc vs Illumina, Inc. — how do they compare? Gigacloud Technology Inc trades at $56.5 (market cap $2.02B), while Illumina, Inc. trades at $266.99 (market cap $39.95B). The key difference: Illumina, Inc. is far larger — about 19.8× Gigacloud Technology Inc's market cap, and Gigacloud Technology Inc is trading nearer its 52-week high, Illumina, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Gigacloud Technology Inc for 21 Days and Illumina, Inc. for 83 Days on average.
| GCT | ILMN | |
|---|---|---|
Market Cap | $2.02B | $39.95B |
Volume | 1,020,985 | 3,169,503 |
Sector | Technology | Health |
52-Week High | $56.42 | $293.69 |
52-Week Low | $25.46 | $91.00 |
Typical Hold Time | 21 Days | 83 Days |
Enterprise Value | $2.14B | $41.31B |
Signals from Pluang's Aura AI — not financial advice
GCT trades at $55.96, up 2.19% today, with a bullish technical signal from moving averages and strong fundamental performance. The company reported Q2 2026 EPS of $1.16, beating estimates of $0.90, continuing a trend of earnings beats. Revenue grew to $1.29 billion in 2025, with net income of $137.37 million and a healthy net margin of 10.65%. The stock is supported by positive cash flow from operations of $190.66 million in 2025.
The outlook for GCT is positive, driven by consistent earnings outperformance and robust profitability metrics like a 32.34% ROE. Risks include potential overbought conditions with an RSI of 72.38 and insider selling activity. Analyst consensus is bullish with a $32.50 price target, though the current price exceeds this, suggesting cautious optimism amid growth execution.
Illumina (ILMN) trades at $267.76, down 2.11% on the day but remains near its 52-week high. The stock exhibits a bullish technical trend with strong moving average signals, while recent earnings beats and a significant return to profitability in 2025 highlight fundamental improvement. Positive sentiment is fueled by S&P 500 inclusion and analyst upgrades, though high valuation ratios present a risk.
The outlook is cautiously optimistic, driven by sequencing growth and AI initiatives, but investors face risks from elevated valuations, competitive pressures, and potential margin volatility. The consensus price target of $241 suggests near-term downside from current levels despite a majority of analysts maintaining a Buy rating.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Gigacloud Technology operates a global B2B e-commerce marketplace for large-parcel goods. It provides a comprehensive solution for furniture manufacturers and retailers with integrated logistics and fulfillment.
Read more on GCT →Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →